TYME | Blue Horseshoe Stocks

Blue Horseshoe Stocks: NFLX Review & More

Netflix, Inc. NFLX – Review

Nearly as often as we signal weekly options ideas, we also formulate longer term ones. Last month on the 12th, we entered our interest in the NFLX 01/25 $290-300 Calls into the log, and after an epic start to 2019, we’ve seen some really great moves.

NFLX stock alone, subsequent to our last alert, has traded for as little as 231.23 up to as high as yesterday’s new top mark of 357.22. That’s an incredible 54% jump in less than five weeks! What that move allowed our selected contracts to do has been nothing short of Earth-shattering.

$290 Calls – Range: 3.80-68.25 – Max Gain: 1696%
$292.50 Calls – Range: 3.28-49.22 – Max Gain: 1400%
$295 Calls – Range: 3.80-60.45 – Max Gain: 1491%
$297.50 Calls – Range: 3.47-59.76 – Max Gain: 1622%
$300 Calls – Range: 2.66-57.69 – Max Gain: 2069%
______

Fresh Options Ideas:
UAL Weekly $85-86 Calls
GT 03/01 $19-20 Calls

We also want to remind our readers to check out our PASO Report from Monday if you missed that, and stay tuned because we’ve got an exclusive interview with the company’s new Chief Operating Officer coming your way very soon!

Extended Watchlist:
PASO, HIPH, LXRX, GERN, TBLT, SCHW, TYME

Blue Horseshoe Stocks: UURAF Update & More

Ucore Rare Metals, Inc. UURAF – Update

We wanted to return to UURAF today, a company we covered last month, which is in the process of designing and building a rare earth material extraction facility near Ketchikan, Alaska which it believes could help the US end its dependency on China for rare earths.

UURAF’s Bokan – Dotson Ridge rare earth property is considered as having some of the richest deposits of rare earth materials in North America, and is so promising that the Alaskan government pledged a $145M funding package to assist in development of the property, including $30M for the new processing facility.

A few weeks ago, the company announced it would be executing a private placement to help cover general expenses as it continues to develop the Bokan property, and just yesterday, we saw that the company has completed the first portion of that deal, quickly making good on its earlier statement:

HALIFAX, Nova Scotia, June 11, 2018 (GLOBE NEWSWIRE) — Ucore Rare Metals Inc. (TSXV:UCU) (OTCQX:UURAF) is pleased to announce that further to its news release dated May 23, 2018, the Company has successfully closed the first tranche of its non-brokered private placement by issuing 6,344,074 units at a subscription price of $0.18 per Unit for gross proceeds of approximately $1,142,000. (>>View Full PR)
_____

VIDEO CHART:

We have also prepared a video presentation of the current UURAF chart.

We are going to be reviving our YouTube channel so after you’re finished viewing the following chart, be sure that you get subscribed with alerts activated, for more great content coming soon!

Tesla, Inc. TSLA – Options Idea

TSLA stock is getting a jolt after KeyBanc analysts predicted as much as a 50% rise in Tesla Model 3 deliveries, and as is the case whenever something causes a stir on the chart, we are going to be looking to take advantage of the situation using some weekly options ideas.

For TSLA, which just recently cracked through its 200DMA, we are going to be looking to the TSLA Weekly 337.50-347.50 Calls for potential quick-strike trades.

Extended Watchlist:
KNDI, SAGE, I, RIGL, GALT, TYME, APRI

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

Our first order of business this morning is to review the recent performance of ECYT, which we initially slated for observation in our report on February 28th. At the time, the stock had been slowly gaining momentum for much of February, and it looked ripe for a more pronounced breakout.

That day, as the stock was trading for as little as 4.51, we witnessed an explosion in volume that has precipitated a very impressive run, persisting for over two weeks up to the present time. Yesterday’s session brought a new high of 11.54 in ECYT, which marks an upswing of 156% in a relatively short time frame.

Valeant Pharma International, Inc. VRX

On Monday morning, we came up with some options ideas for VRX, which we noted was “ready for a bottom bounce”. We also made reference to a huge Form-4 buy of $108.8M came in as well, which led us to postulate that “for now the stock has gone as low as it’s going to go.”

We couldn’t have been any more spot-on in our assessment of VRX, and the result has been a solid performance for the short-term calls we put on watch, the VRX Weekly $15 & $15.50 Calls. The $15’s ran from .65-1.15 for a gain of 77%, while the $15.50’s moved from a low of .30 to .71, an increase of 137%

We had some longer-term ideas as well which we will likely come back to in an upcoming report, as it appears VRX will continue to head up. On that note, we’ll also look to roll up our strike prices on the weekly calls to the $16 & $16.50’s.

_______________

Fresh Options Idea:

Walmart, Inc. WMT 04/20 $95-97.50 Calls

Extended Watchlist:
RKDA, EXPR, NCTY, VYGR, TYME, MARA